Emily M. Le

Array ( [id] => 42877 [patent_doc_number] => 07776343 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-17 [patent_title] => 'Immunogenic complexes and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 09/506011 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 11972 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776343.pdf [firstpage_image] =>[orig_patent_app_number] => 09506011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619950 [patent_doc_number] => 06943233 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-13 [patent_title] => 'Cyclic peptides and aids vaccines' [patent_app_type] => utility [patent_app_number] => 10/110853 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5216 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943233.pdf [firstpage_image] =>[orig_patent_app_number] => 10110853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556339 [patent_doc_number] => 07470506 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-30 [patent_title] => 'Fitness assay and associated methods' [patent_app_type] => utility [patent_app_number] => 09/720276 [patent_app_country] => US [patent_app_date] => 1999-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 23226 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470506.pdf [firstpage_image] =>[orig_patent_app_number] => 09720276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6663663 [patent_doc_number] => 20030202989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'USE OF TOXIN PEPTIDES AND/OR AFFINITY HANDLES FOR DELIVERING COMPOUNDS INTO CELLS' [patent_app_type] => new [patent_app_number] => 09/077439 [patent_app_country] => US [patent_app_date] => 1999-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10749 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20030202989.pdf [firstpage_image] =>[orig_patent_app_number] => 09077439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882879 [patent_doc_number] => 20010049351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'METHOD OF DETERMINING DOWN-REGULATION OF THE EXPRESSION OF HIV CORECEPTOR, CCR5 WITH PRODUCT R' [patent_app_type] => new [patent_app_number] => 09/257739 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3732 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049351.pdf [firstpage_image] =>[orig_patent_app_number] => 09257739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6647570 [patent_doc_number] => 20030104485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'ANTIBODIES SPECIFIC FOR OSTEOPROTEGERIN BINDING PROTEINS AND METHOD OF USE' [patent_app_type] => new [patent_app_number] => 09/079569 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7895 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104485.pdf [firstpage_image] =>[orig_patent_app_number] => 09079569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1182043 [patent_doc_number] => 06737513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same' [patent_app_type] => B1 [patent_app_number] => 09/067447 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 45175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737513.pdf [firstpage_image] =>[orig_patent_app_number] => 09067447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6886445 [patent_doc_number] => 20010019714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'HIV-SPECIFIC CYTOTOXIC T-CELL RESPONSES' [patent_app_type] => new [patent_app_number] => 09/055744 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4580 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20010019714.pdf [firstpage_image] =>[orig_patent_app_number] => 09055744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1219645 [patent_doc_number] => 06703019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Cationized antibodies against intracellular proteins' [patent_app_type] => B1 [patent_app_number] => 08/931666 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4971 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703019.pdf [firstpage_image] =>[orig_patent_app_number] => 08931666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923028 [patent_doc_number] => 07319000 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-01-15 [patent_title] => 'Compositions and methods for eliciting immune or anti-infective responses' [patent_app_type] => utility [patent_app_number] => 08/869386 [patent_app_country] => US [patent_app_date] => 1997-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 20577 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319000.pdf [firstpage_image] =>[orig_patent_app_number] => 08869386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232602 [patent_doc_number] => 06090382 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Human antibodies that bind human TNF.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/599226 [patent_app_country] => US [patent_app_date] => 1996-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23937 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090382.pdf [firstpage_image] =>[orig_patent_app_number] => 599226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167882 [patent_doc_number] => 06753162 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells' [patent_app_type] => B1 [patent_app_number] => 08/394388 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 56 [patent_no_of_words] => 26366 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753162.pdf [firstpage_image] =>[orig_patent_app_number] => 08394388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710260 [patent_doc_number] => 07056689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'Methods of treating and detecting cancer using viruses' [patent_app_type] => utility [patent_app_number] => 08/260536 [patent_app_country] => US [patent_app_date] => 1994-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8614 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056689.pdf [firstpage_image] =>[orig_patent_app_number] => 08260536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153639 [patent_doc_number] => 06764682 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-20 [patent_title] => 'Adjuvant compositions containing more than one adjuvant' [patent_app_type] => B1 [patent_app_number] => 08/261194 [patent_app_country] => US [patent_app_date] => 1994-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10460 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/764/06764682.pdf [firstpage_image] =>[orig_patent_app_number] => 08261194 [rel_patent_id] =>[rel_patent_doc_number] =>)